elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26773803-08BC564E-7DE2-485B-B63E-9BB90EE6B3B7
Q26773803-08BC564E-7DE2-485B-B63E-9BB90EE6B3B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26773803-08BC564E-7DE2-485B-B63E-9BB90EE6B3B7
Epigenetic treatment of solid tumours: a review of clinical trials
P2860
Q26773803-08BC564E-7DE2-485B-B63E-9BB90EE6B3B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26773803-08BC564E-7DE2-485B-B63E-9BB90EE6B3B7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
279edd7034e68db594d46665179966eb9d600842
P2860
Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study.